[Modern systemic therapies for atopic dermatitis : Which factors determine the choice of therapy?]
{{output}}
For the treatment of moderate to severe atopic dermatitis (AD), two groups of modern systemic therapies with a total of five drugs are currently approved in Germany: biologics (dupilumab, tralokinumab) and "small molecules" (abrocitinib, baricitinib, upadaciti... ...
